Bayesian Hierarchical Modelling for Histology-Independent Time-to-Event Outcomes in the NICE Single Technology Appraisal of Pembrolizumab for Solid Tumours with MSI-H/dMMR: External Assessment Group Perspective.

Pharmacoeconomics

Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+ (MUMC+), Maastricht, The Netherlands.

Published: June 2024

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11126505	PMC
http://dx.doi.org/10.1007/s40273-024-01381-z	DOI Listing

Publication Analysis

bayesian hierarchical

hierarchical modelling

modelling histology-independent

histology-independent time-to-event

time-to-event outcomes

outcomes nice

nice single

single technology

technology appraisal

appraisal pembrolizumab

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!